Watchlist Price Alert

HUTCHMED (China) Limited (HCM)

NASDAQ: HCM · Real-Time Price · USD

15.20

0.36 (2.43%)

At close: Jun 23, 2025, 3:54 PM

2.43% (1D)

Bid	15.14
Market Cap	2.73B
Revenue (ttm)	630.2M
Net Income (ttm)	37.73M
EPS (ttm)	0.2
PE Ratio (ttm)	76
Forward PE	27.07
Analyst	Hold

Ask	15.34
Volume	50,114
Avg. Volume (20D)	96,224
Open	15.13
Previous Close	14.84
Day's Range	14.99 - 15.23
52-Week Range	11.51 - 21.50
Beta	0.60

About HCM

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol HCM

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for HCM stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

2 months ago

+12.31%

HUTCHMED shares are trading higher after the compa... Unlock content with Pro Subscription

3 months ago

+8.23%

HUTCHMED shares are trading higher. The company reported FY24 financial results.

News

Just now · zacks.com

How Much Upside is Left in HUTCHMED (HCM)? Wall Street Analysts Think 73.52%

The average of price targets set by Wall Street analysts indicates a potential upside of 73.5% in HUTCHMED (HCM). While the effectiveness of this highly sought-after metric is questionable, the positi...

1 day ago · seekingalpha.com

Paycom Software: Automating Payroll And HCM Solutions; Initiate With 'Buy'

I am initiating Paycom with a 'buy' rating and a $280 fair value, driven by strong automation-focused HCM solutions. Paycom's innovations like Beti and GONE automate payroll and time-off processes, su...

2 weeks ago · zacks.com

Wall Street Analysts See a 68.3% Upside in HUTCHMED (HCM): Can the Stock Really Move This High?

The mean of analysts' price targets for HUTCHMED (HCM) points to a 68.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts...

1 month ago · businesswire.com

Fragmented HCM systems jeopardize business efficiency, Paycom research reveals

OKLAHOMA CITY--(BUSINESS WIRE)--Paycom Software, Inc. (NYSE: PAYC) (“Paycom”), a leading provider of comprehensive, cloud-based human capital management software, discovered surveyed businesses rely o...

2 months ago · proactiveinvestors.co.uk

HUTCHMED shares rise 10% as Phase II gastric cancer trial hits key milestone

Shares in Hutchmed (China) Ltd (AIM:HCM, NASDAQ:HCM, HKG:0013) rose 10% in early trading on Tuesday after the biopharma company announced it had completed patient enrolment for a key phase II trial of...

2 months ago · businesswire.com

Bristol Myers Squibb Provides Update on Phase 3 ODYSSEY-HCM Trial

PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #Camzyos--Bristol Myers Squibb Provides Update on Phase 3 ODYSSEY-HCM Trial.

2 months ago · zacks.com

3 Internet Delivery Services Stocks in Focus Amid Industry Challenges

Tariff war, inflationary pressure and still-high interest rates are major concerns for the Zacks Internet - Delivery Services industry. However, efforts to adopt consumer preferences and technological...

2 months ago · benzinga.com

Edgewise Therapeutics Sees Meaningful HCM Treatment Gains With EDG-7500 In Phase 2 Study

Edgewise Therapeutics, Inc., EWTX on Wednesday reported topline data of EDG-7500 from the Phase 2 CIRRUS-HCM four-week trial in participants with obstructive or nonobstructive Hypertrophic Cardiomyopa...